Caring for our patients is our biggest priority. Our clinics offer expert services in several specialized areas of genetics.
Angelman Syndrome Study
Ovid Therapeutics is sponsoring a clinical research study called the STARS study. The STARS study will evaluate the safety and effectiveness of an investigational medicine on various aspects associated with Angelman syndrome. The STARS study will enroll approximately 75 people in a Phase 2 double-blind placebo-controlled randomized study.
Fragile X Syndrome Program
Fragile X syndrome (FXS) is a genetic condition that causes intellectual disability, behavioral and learning challenges and various physical characteristics. Though FXS occurs in both genders, males are more frequently affected than females, and generally with greater severity
Longitudinal Studies of the Glycoproteinoses
This project seeks to obtain clinical and laboratory information about individuals affected with a glycoprotein storage disorder including aspartyglucosaminuria, fucosidosis, galactosialidosis, alpha-mannosidosis, beta-mannosidosis, mucolipidosis II, mucolipidosis III, Schindler disease, and sialidosis.
Rett Syndrome Program
Through clinical care, research, and advocacy, the Rett Syndrome and Related Disorders Program of the Greenwood Genetic Center dedicated to the benefit of all individuals and families impacted by these conditions.